Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Imagine this: You walk into your doctor and get your yearly flu vaccine and a yearly dose of your weight-loss injection. If Eli Lilly has its way, this may be the future of obesity care.

Imagine this: You walk into your doctor and get your yearly flu vaccine and a yearly dose of your weight-loss injection. If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly ...

"CO2 in carbonated water may promote weight loss by enhancing glucose uptake and metabolism in red blood cells," according to researchers Getty Plain seltzer water may give you a weight-loss ...

Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed. The big pharma companies Novo Nordisk and Eli Lilly look to be the main ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has approved Novo Nordisk’s semaglutide for heart disease and Eli Lilly’s ...

Shares of Eli Lilly & Co. were headed for their worst ... citing slower-than-expected growth in sales of its diabetes and weight-loss drugs. “While the U.S. incretin market grew 45% compared ...

Eli Lilly's stock price finished Jan. 16 down 21% from a peak it set last September. The sales trajectory of Mounjaro and Zepbound tapered off in the second half of 2024. An oral weight-loss ...

Eli Lilly unexpectedly lowered ... Meanwhile, its non-weight loss drug portfolio is also growing nicely. From a valuation perspective, Lilly trades at a forward price-to-earnings (P/E) of 25.4 ...

Eli Lilly lowered its sales expectations for its weight-loss drug, Zepbound ... Eli Lilly has officially entered the legal battle between the Outsourcing Facilities Association (OFA) and FarmaKeio ...

On Friday, Guggenheim analysts revised their price target for Eli Lilly (NYSE:LLY ... Analysts predict that profit and loss trends will likely mirror those seen in previous years.